Quarterly ResultMay 12, 2026, 04:13 PM
Savara's Net Loss Widens to $37.3M in Q1 2026; R&D Up 22.1%
AI Summary
Savara Inc. reported a net loss of $37.3 million for Q1 2026, a significant increase from $26.6 million in Q1 2025, with diluted loss per share rising to $0.15. This was primarily driven by a 22.1% increase in R&D expenses and a 68.4% rise in general and administrative costs. The company also amended its Hercules Loan Agreement, potentially allowing for up to $105 million in additional term loans upon achieving an Approval Milestone for its MOLBREEVI program.
Key Highlights
- Net loss for Q1 2026 increased to $37.3 million from $26.6 million in Q1 2025.
- Diluted net loss per share rose to $0.15 in Q1 2026 from $0.12 in Q1 2025.
- Research and development expenses increased 22.1% to $23.4 million.
- General and administrative expenses surged 68.4% to $15.6 million.
- Net cash used in operating activities was $33.0 million for Q1 2026.
- Cash and cash equivalents stood at $38.8 million as of March 31, 2026.
- Amended Hercules Loan Agreement allows up to $105 million in additional term loans.
- Accumulated deficit reached $645.4 million as of March 31, 2026.